Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to print (Opens in new window) SoloHealth has ...

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia for up to 10 hours, a condition impacting approximately 128 million adults in the United ...

A new eye drop, Vizz, was recently FDA approved and is helping people regain near vision without glasses. Originally used for ...

LNZ100 shows superior efficacy and safety in presbyopia treatment, with a strong probability of FDA approval by August 2025. LNZ100 outperforms competitors Vuity and Qlosi, offering faster and greater ...

Presbyopia is defined as age-related loss of near vision that affects nearly everyone over age 45. The FDA has approved Vizz, an aceclidine ophthalmic solution 1.44%, making it the first and only ...

New research demonstrated that special eye drops allowed patients to read extra lines on an eyesight chart for up to two years. Reading time: Reading time 3 minutes If you haven’t yet experienced it ...

What is it, and why does it matter? Vizz (aceclidine ophthalmic solution) is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as ...

SEATTLE, Washington — An overwhelming majority of people with age-related macular degeneration would rather test their vision with an iPad app than with traditional methods, a new study shows. "One of ...